Quantcast

Latest Rosuvastatin Stories

2014-07-31 23:23:21

Lawsuit Funding Network has secured investors to assist victims who have developed Type-II Diabetes while either taking Lipitor or Crestor. Lake Zurich IL (PRWEB) July 31, 2014 Lipitor/Crestor is prescribed to people who have been diagnosed with high cholesterol. This drug contains the active ingredient atrovastatin and was marketed to patients as a means of lowering cholesterol;it has been alleged however that use of this drug has been linked to the development of Type-II Diabetes. It...

2014-06-04 23:01:36

The just-filed lawsuit was filed by a group of consumers who allege that the maker and distributor of Crestor, prescribed to lower cholesterol levels, allegedly hid information on the drug’s serious, adverse health reactions. Port Washington, NY (PRWEB) June 04, 2014 Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of consumers who have suffered injuries due to dangerous drugs comments on a recent lawsuit filed on May 29, 2014 in the United...

2014-06-03 23:01:37

The Firm is evaluating Lipitor lawsuits on behalf of patients who allegedly developed Type 2 diabetes due to their use of the statin medication. New York, New York (PRWEB) June 03, 2014 As Lipitor lawsuit claims (http://www.thelipitorlawsuit.com/) involving allegations that the popular statin drug causes Type 2 diabetes continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a newly-released study has found that high-potency doses of Lipitor and other statins may...

2014-05-13 16:26:32

THOUSAND OAKS, Calif., May 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of data from the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) study in the Journal of the American Medical Association (JAMA). Results from the 12-week study, which evaluated 1,896 patients with high cholesterol, showed treatment with subcutaneous evolocumab (140 mg every two weeks or 420 mg monthly) in combination with...

2014-04-01 23:01:39

Susquehanna Health (SH) Cardiologist Dr. Liran Blum said new guidelines established by the American College of Cardiology (ACC) and American Heart Association (AHA) regarding the recommended use of cholesterol-reducing drugs called statins are appropriate and should be viewed primarily as guidelines when determining a patient’s course of treatment for the prevention of cardiovascular events such as heart attacks or strokes. “I think the guidelines and the recent [Duke University] study...

2014-03-30 08:20:05

Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Yesterday THOUSAND OAKS, Calif., March 30, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced new detailed data from two Phase 3 pivotal studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant...

2014-03-25 23:02:29

Federal litigation involving Pfizer's cholesterol-lowering drug Lipitor has been consolidated before a single judge in South Carolina. (PRWEB) March 25, 2014 The law firm McSweeney / Langevin continues to advise women regarding potential legal claims regarding a possible link between use of Lipitor and the development of type 2 diabetes. Recently, federal litigation involving Pfizer, and plaintiffs alleging Lipitor caused type 2 diabetes, was centralized in South Carolina following...

2014-02-12 08:29:41

New Published Study Reveals BergaMet(TM) Added to Statins Enhances Lipid Lowering and Artery Health DENVER, Feb. 12, 2014 /PRNewswire/ -- New published research reveals that a highly concentrated proprietary extract of the Calabrian bergamot fruit called BergaMet(TM) (38% citrus bergamot extract, NathealthSolutions) enhances the effect of the lipid lowering drug rosuvastatin (Crestor(TM)) when given to patients with elevated cholesterol. Led by cardiologists Franco Romeo and Vincenzo Mollace,...

2014-01-28 16:26:04

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Jan. 28, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) trial evaluating evolocumab in combination with statin therapy in patients with high cholesterol met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week...

2013-09-11 23:04:57

Baron and Budd reports on study alleging that Lipitor use may cause a significantly increased risk of type 2 diabetes compared to other drugs in its class LOS ANGELES (PRWEB) September 11, 2013 A study published on May 23, 2013 in the British Medical Journal alleges that many high-potency statins such as Lipitor may increase the risk of developing type 2 diabetes. Statins are commonly used to lower cholesterol and reduce the risk of cardiovascular disease; however the study suggests a...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related